The rise and fall and rise of benzodiazepines: a return of the stigmatized and repressed

Affiliations

¹ Departments of Psychiatry and Behavioral Neurosciences and Anesthesiology, Wayne State University, Detroit, Michigan, USA.
² Discipline of Psychiatry, Faculty of Medicine and Health, Sydney Medical School, Nepean Clinical School, University of Sydney, Sydney, Australia.
³ Department of Psychiatry, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA.
⁴ Department of Health Sciences, University of Florence, Florence, Italy.
⁵ Department of Psychiatry & Neuropsychology, Maastricht University, Maastricht, The Netherlands.
⁶ Department of Psychiatry, University of Buffalo, Buffalo, New York, USA.
⁷ Department of Psychiatry, University of Colorado, Denver, Colorado, USA.
⁸ Department of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
⁹ Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹⁰ Department of Psychiatry, Harvard University, Boston, Massachusetts, USA.
¹¹ Center for the Study of Drug Development, Department of Immunology, Tufts University, Boston, Massachusetts, USA.

Editorial

Richard Balon et al. Braz J Psychiatry. 2020.

. 2020;42(3):243-244.

doi: 10.1590/1516-4446-2019-0773. Epub 2020 Mar 9.

¹ Departments of Psychiatry and Behavioral Neurosciences and Anesthesiology, Wayne State University, Detroit, Michigan, USA.
² Discipline of Psychiatry, Faculty of Medicine and Health, Sydney Medical School, Nepean Clinical School, University of Sydney, Sydney, Australia.
³ Department of Psychiatry, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA.
⁴ Department of Health Sciences, University of Florence, Florence, Italy.
⁵ Department of Psychiatry & Neuropsychology, Maastricht University, Maastricht, The Netherlands.
⁶ Department of Psychiatry, University of Buffalo, Buffalo, New York, USA.
⁷ Department of Psychiatry, University of Colorado, Denver, Colorado, USA.
⁸ Department of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
⁹ Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹⁰ Department of Psychiatry, Harvard University, Boston, Massachusetts, USA.
¹¹ Center for the Study of Drug Development, Department of Immunology, Tufts University, Boston, Massachusetts, USA.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest.

1. Greenblatt DJ, Shader RI. Meprobamate: a study of irrational drug use. Am J Psychiatry. 1971;127:1297–303. - PubMed
1. Benasi G, Guidi J, Offidani E, Balon R, Rickels K, Fava GA. Benzodiazepines as a monotherapy in depressive disorders: a systematic review. Psychother Psychosom. 2018;87:65–74. - PubMed
1. Offidani E, Guidi J, Tomba E, Fava GA. Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom. 2013;82:355–62. - PubMed
1. Quagliato LA, Coaci F, Shader RI, Silberman EK, Starcevic V, Balon R, et al. Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: a meta-analysis of common side effects in acute treatment. J Psychopharmacol. 2019;33:1340–51. - PubMed
1. American Psychiatric Association (APA). Benzodiazepine dependence, toxicity, and abuse. A Task Force Report. Washington: APA; 1990.